Андрология и генитальная хирургия. 2016; 17: 34-39
Эндофаллопротезирование однокомпонентным полуригидным протезом у больного с артериовенозной фистулой кавернозной артерии и развитием приапизма
https://doi.org/10.17650/2070-9781-2016-17-1-34-39Аннотация
Фаллопротезирование у больных с различными сроками и гемодинамическими типами приапизма является дискуссионной проблемой. Возможным методом лечения ишемического приапизма можно считать установку ригидных протезов полового члена, особенно если другие методы консервативного и оперативного лечения были неэффективны, а срок патологической эрекции превышает 36–72 ч. В статье приведен пример лечения подобного больного. Для диагностики были использованы современные методы визуализации, такие как цветовое допплеровское картирование сосудов полового члена, селективная илиакография, компрессионная соноэластография. С помощью них был установлен топически правильный диагноз и обосновано применение метода лечения
Список литературы
1. Montague D. K., Jarow J., Broderick G. A. et al. American Urological Association guideline on the management of priapism. J Urol 2003;170(4 Pt 1):1318–24.
2. Kulmala R. V., Lehtonen T. A., Tammela T. L. Priapism, its incidence and seasonal distribution in Finland. Scand J Urol Nephrol 1995;29(1):93–6.
3. Eland I. A., van der Lei J., Stricker B. H. et al. Incidence of priapism in the general population. Urology 2001;57(5):970–2.
4. Furtado P. S., Costa M. P., Ribeiro do Prado Valladares F. et al. The prevalence of priapism in children and adolescents with sickle cell disease in Brazil. Int J Hematol 2012;95(6):648–51.
5. Lionnet F., Hammoudi N., Stojanovic K. S. et al. Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica 2012;97(8):1136–41.
6. Olujohungbe A. B., Adeyoju A., Yardumian A. et al. A prospective diary study of stuttering priapismin adolescents and young men with sickle cell anemia: report of an international randomized control trialthe priapism in sickle cell study. J Androl 2011;32(4):375–82.
7. Adeyoju A. B., Olujohungbe A. B., Morris J. et al. Priapism in sickle-cell disease; incidence, risk factors and complications – an international multicentre study. BJU Int 2002;90(9):898–902.
8. Broderick G. A., Kadioglu A., Bivalacqua T. J. et al. Priapism: pathogenesis, epidemiology, and management. J Sex Med 2010;7(1 Pt 2):476–500.
9. Levey H. R., Kutlu O., Bivalacqua T. J. Medical management of ischemic stuttering priapism: a contemporary review of the litera ture. Asian J Androl 2012;14(1):156–63.
10. Morrison B. F., Burnett A. L. Stuttering priapism: insights into pathogenesis and management. Curr Urol Rep 2012;13(4):268–76.
11. Montague D. K., Jarow J., Broderick G. A. et al. American Urological Association guideline on the management of priapism. J Urol 2003;170(4 Pt 1):1318–24.
Andrology and Genital Surgery. 2016; 17: 34-39
Endofalloprosthesis with a one-component semirigid prosthesis in a patient with an arteriovenous fistula of the cavernous artery and the development of priapism
https://doi.org/10.17650/2070-9781-2016-17-1-34-39Abstract
Phalloprosthesis in patients with various durations and different hemodynamic types of priapism is a disputable problem. Rigid penile prosthesis placement may be deemed to be a possible method for the torpid treatment of ischemic priapism, particularly if other medical and surgical procedures have been ineffective and the time of pathological erection is over 36–72 hours. The paper gives an example of how such a patient was treated. Imaging techniques, such as color Doppler mapping of the penile vessels, selective iliacography, and compression sono elastography, were used for diagnosis. These techniques could make a correct diagnosis and provide a rationale for endofalloprosthesis.
References
1. Montague D. K., Jarow J., Broderick G. A. et al. American Urological Association guideline on the management of priapism. J Urol 2003;170(4 Pt 1):1318–24.
2. Kulmala R. V., Lehtonen T. A., Tammela T. L. Priapism, its incidence and seasonal distribution in Finland. Scand J Urol Nephrol 1995;29(1):93–6.
3. Eland I. A., van der Lei J., Stricker B. H. et al. Incidence of priapism in the general population. Urology 2001;57(5):970–2.
4. Furtado P. S., Costa M. P., Ribeiro do Prado Valladares F. et al. The prevalence of priapism in children and adolescents with sickle cell disease in Brazil. Int J Hematol 2012;95(6):648–51.
5. Lionnet F., Hammoudi N., Stojanovic K. S. et al. Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica 2012;97(8):1136–41.
6. Olujohungbe A. B., Adeyoju A., Yardumian A. et al. A prospective diary study of stuttering priapismin adolescents and young men with sickle cell anemia: report of an international randomized control trialthe priapism in sickle cell study. J Androl 2011;32(4):375–82.
7. Adeyoju A. B., Olujohungbe A. B., Morris J. et al. Priapism in sickle-cell disease; incidence, risk factors and complications – an international multicentre study. BJU Int 2002;90(9):898–902.
8. Broderick G. A., Kadioglu A., Bivalacqua T. J. et al. Priapism: pathogenesis, epidemiology, and management. J Sex Med 2010;7(1 Pt 2):476–500.
9. Levey H. R., Kutlu O., Bivalacqua T. J. Medical management of ischemic stuttering priapism: a contemporary review of the litera ture. Asian J Androl 2012;14(1):156–63.
10. Morrison B. F., Burnett A. L. Stuttering priapism: insights into pathogenesis and management. Curr Urol Rep 2012;13(4):268–76.
11. Montague D. K., Jarow J., Broderick G. A. et al. American Urological Association guideline on the management of priapism. J Urol 2003;170(4 Pt 1):1318–24.
